Press Releases
The European Commission Approves Pfizer’s Revatio for the Treatment...
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years...
Press Releases
Almac Introduces selectAZyme
Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs...
Press Releases
ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase...
ISTA Pharmaceuticals, Inc. announced positive, topline results from its Phase 2 dose-ranging, environmental clinical trial of bepotastine besilate nasal spray for the treatment of symptoms...
Press Releases
Wockhardt receives US FDA approval for generic version of...
Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing 5mg and 10mg tablets...
Press Releases
CIT/ABC acquires assets of LAB Research Inc.
Applied Biology Company (ABC), the holding company of CIT Safety & Health Research Laboratories (CIT), a leading player among European preclinical CROs, announces today the...
Press Releases
AMRI Announces Development and Commercial Supply Agreement with Parnell...
AMRI announced that it has entered into a development and long term exclusive commercial supply agreement with Parnell Manufacturing Pty Ltd (Parnell), an Australian company...
Press Releases
Lundbeck’s partner Mochida receives approval of Lexapro in Japan
H. Lundbeck A/S announced that our partner Mochida Pharmaceutical Co., Ltd. (Mochida) has obtained approval of Lexapro® 10 mg (escitalopram) from the Japanese Ministry...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.